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Background: High-power short-duration (HPSD) recently emerged as a new approach
to radiofrequency (RF) catheter ablation. However, basic and clinical data supporting its
effectiveness and safety is still scarce.
Objective: We aim to characterize HPSD with an advanced virtual model, able to
assess lesion dimensions and complications in multiple conditions and compare it to
standard protocols.
Methods: We evaluate, on both atrium and ventricle, three HPSD protocols (70 W/8 s,
80 W/6 s, and 90 W/4 s) through a realistic 3D computational model of power-controlled
RF ablation, varying catheter tip design (spherical/cylindrical), contact force (CF), blood
flow, and saline irrigation. Lesions are defined by the 50◦C isotherm contour. Ablations
are deemed safe or complicated by pop (tissue temperature >97◦C) or charring (blood
temperature >80◦C). We compared HPSD with standards protocols (30–40 W/30 s). We
analyzed the effect of a second HPSD application.
Results: We simulated 432 applications. Most (79%) associated a complication,
especially in the atrium. The three HPSD protocols performed similarly in the atrium, while
90 W/4 s appeared the safest in the ventricle. Low irrigation rate led frequently to charring
(72%). High-power short-duration lesions were 40–60% shallower and smaller in volume
compared to standards, although featuring similar width. A second HPSD application
increased lesions to a size comparable to standards.
Conclusion: High-power short-duration lesions are smaller in volume and more
superficial than standards but comparable in width, which can be advantageous in the
atrium. A second application can produce lesions similar to standards in a shorter time.
Despite its narrow safety margin, HPSD seems a valuable new clinical approach.
Keywords: radiofrequency ablation, high-power short-duration, computational modeling, lesion science, ablation
catheter
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INTRODUCTION
Radiofrequency (RF) catheter ablation is the cornerstone
treatment for cardiac arrhythmias. Radiofrequency lesions
depend mainly on the power delivered to the tissue, catheter
stability, and contact force (CF) over time (1, 2). In the
initial development of RF ablation in the 90’s, a power
titration was performed according to efficacy and safety targets
(temperature registered by the catheter, impedance drop, signal
analysis), between 20 and 50W. Clinical experience and extensive
research in the field, aiming at maximizing the lesion size and
minimizing the risk of complications, led to protocols where
the power and duration have been standardized according to
the arrhythmogenic substrate. For 4 mm-tip catheter the general
consensus is to limit the maximum power to 30–50W over 30–
90 s (2, 3). Nevertheless, catheter stability and optimal CF over
time are challenging to keep in a beating heart. This may result
in smaller and inconsistent lesions that hamper the creation of
effective lines of electrical block and prolong the duration of
the procedures.
Aimed at overcoming these limitations of conventional
protocols, a new RF ablation paradigm has emerged in the last
years. Known as high-power short-duration (HPSD) ablation,
these protocols are based on increasing maximum power
and markedly shortening the application. A heterogeneity of
power/duration settings, from 35 to 60W and 6 to 15 s, have
been proposed and tested for pulmonary vein isolation (4). Some
groups have investigated more aggressive protocols with power
ranging from 70 to 90W during 4–8 s (5, 6). However, lesion
science of HPSD is largely unknown and the results of in-vivo
and in-vitro studies comparing these lesions to standard ones
are contradictory (6–8). Moreover, clinical data supporting their
effectiveness and safety is limited (9, 10). Additionally, as most of
the clinical studies are on pulmonary vein isolation, experience
on other atrial substrates is limited and absent on the ventricle.
The development of advanced virtual models for RF ablation
allows to simulate lesion formation mimicking infinite scenarios.
A systematic and realistic evaluation of RF ablation can be
performed by changing parameters as catheter type and shape,
ablation protocol, blood and irrigation flow, CF, or cardiac
chamber. This will grant an understanding of RF lesion formation
and its complications beyond that obtained through classical
in-vitro and in-vivo assessment. This novel research approach
proves of particular interest in early stages of new ablation
strategies like HPSD.
We aim to systematically characterize different HPSD ablation
protocols by means of an advanced virtual model developed
by our group (11). Lesion dimensions and complications will
be evaluated and compared to those of standard conventional




Our computational model of RF catheter ablation simulates a
human heart considering fixed conditions, to standardize the
comparison of the different ablation settings. The mathematical
model, based on an in-vitro experimental setup (12), is built
within a three-dimensional computational framework described
previously by our group (11). It considers tissue elasticity,
thermoelectric interaction between electrode and ablation area,
and convective cooling by blood flow and irrigation saline. In
Petras et al. (11) the model has also been validated against in-
vitro experimental data for standard RF protocols. A detailed
description of themodel is given in the Supplementary Material.
The biophysical properties of the tissue introduced in the
model are tissue density, thermal conductivity and heat capacity
(Supplementary Table 1 of the Supplementary Material),
whose values are based on experimental data registered in IT’IS
database (13). Heat expansion through the tissue occurs in a
radial manner. We assume a linear temperature-dependent
decrease of specific heat (0.42 per 1◦C increase) and thermal
conductivity (0.05% per 1◦C increase), and a linear temperature-
dependent increase in electrical conductivity (0.15% per 1◦C
increase), following the experimental studies of Haines and
Watson (14) and Rossmanna and Haemmerich (15). Tissue
heterogeneity may influence the biophysical properties, however,
due to the lack of data in this respect, we neglected this feature in
themodel. The governing equation for the thermal problem is the
Bioheat Equation, while the blood flow and its interaction with
the irrigation saline in the blood compartment are modeled using
the incompressible Navier-Stokes equations for fluid dynamics
(16). The model is solved by finite elements through our self-
developed software in FEniCS-HPC (www.fenics-hpc.org). The
computational geometry features about 5,000,000 tetrahedra
with a maximum element size of 1mm and a minimum of
0.01mm in the area of the electrode, where higher computational
accuracy is needed. Simulations were carried out on the cluster
Hipatia of BCAM (the Basque Center for Applied Mathematics,
Bilbao, Spain) which features 18 nodes (1 with Nvidia Tesla
K40 GPU) for 624 cores with 4 TB RAM and Infiniband
network connectivity.
Electrode Tip Design
We consider two open-irrigated electrode designs used in
clinical practice, and also used in a previous experimental study
performed by our group (12), one with a hemispherical tip and
one with a cylindrical tip (7 French, 3.5mm length). Both feature
six irrigation pores (0.5mm diameter) (Figure 1).
Lesion Assessment
At 50◦C, cardiomyocytes exhibit a permanent loss of excitability,
as well as a thermally induced necrosis leading to irreversible
myocardial injury, which is the target of RF ablation. In
light of the above consideration, virtual lesions are identified
by the isotherm contour of 50◦C within the cardiac tissue,
considering irreversible tissue damage at 50◦C (17, 18).
The assessment of the lesion dimensions is performed with
ParaView (19). We measure lesion volume, maximum width
(W), maximum depth (D), and depth at the maximum width
(DW) (Figure 1), considering the zero at the undeformed
endocardial surface.
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FIGURE 1 | Virtual lesion created with the two considered catheters. (A) Spherical tip and (B) Cylindrical tip. The area of irreversible tissue lesion (tissue temperature
≥50◦C) is delimited by the blue line. Measurements: maximum depth (D), depth at the maximum diameter (DW), maximum diameter (W).
Complications Assessment
A steam pop is considered to occur when tissue temperature
≥97◦C. We use a temperature threshold <100◦C to account
for the natural fluctuation of water boiling point depending on
tissue composition and other physical conditions (20). Although
reaching a boiling temperature doesn’t automatically result in
pop, given the seriousness of this complication, we equate the
risk of pop with the occurrence of it. Charring is assumed to be
initiated at blood temperature of 80◦C. The occurrence of one
of the two complications ends the application, precluding the
development of the other. Applications that finish without any
complication are deemed safe.
Ablation Settings
Three different HPSD ablation protocols are used (70 W/8 s,
80 W/6 s, 90 W/4 s) delivered in power-control mode without
temperature limit. The model considers a fixed impedance of 120
Ohms, mimicking the behavior of contemporary RF generators,
that vary the RF current delivery according to impedance
changes, to ensure the delivery of the selected power. Since the
chosen power is a fixed parameter, changes in baseline impedance
and during ablation are disregarded. Each protocol is simulated
on the atrium and the ventricle. All virtual applications are
performed perpendicularly to the endocardium. Based on clinical
data, we assume similar biophysical properties for both cardiac
regions, only differenced by thickness (6mm in atrium, 12mm in
ventricle) (21). Four increasing CF from 5 to 20 g are simulated
resulting in progressive deformation of the tissue.
In order to simulate representative cardiac regions (22) three
blood flow velocities are used: no-blood flow (0 m/s), as expected
in epicardium or below a valve leaflet; low-blood flow (0.1 m/s),
as expected in healthy atrium or pulmonary veins; and high-
blood flow (0.5 m/s), as expected at the cavo-tricuspid annulus,
ventricle, or outflow tracts.
Additionally, three different saline catheter irrigation rates,
are simulated for each HPSD protocol: normal, high, and very
TABLE 1 | Summary of the different ablation settings and physiological scenarios
considered combining catheter tip, contact force, power, duration, irrigation rate,
blood flow, and cardiac chamber.
Ablation settings Catheter tip Spherical
Cylindrical




Power/Duration 70 W/8 s
80 W/6 s
90 W/4 s










high rate (17, 30, and 60 ml/min, respectively, according to the
technical specifications of the commercial catheters).
All simulated combinations are summarized in Table 1.
Design of the Study
The study is structured in three steps:
A. We evaluate the safety of the different HPSD ablation settings
and protocols.
B. We assess the efficacy of HPSD protocols identified as the
safest in the previous step. For both chambers, we compute
HPSD lesion sizes and compare them with those generated
by standard applications according to the current standard-
of-care (30 W/30 s for the atrium and 30–40 W/30 s for the
ventricle, CF 10 g, irrigation rate 17 ml/min) (3, 23).
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FIGURE 2 | Safety outcomes of HPSD protocols according to the different parameters in Table 1. HBF, high blood-flow (0.5 m/s); LBF, low blood-flow (0.1 m/s); NBF,
no blood-flow (0.0 m/s).
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C. We analyze the impact of a second HPSD application on top
of the first one. We evaluate changes in terms of safety and
lesion size at increasing time intervals (2, 4, 6, 8, and 10 s)
between the first and second application. Irrigation rate is kept
at 2 ml/min between the two applications, while the protocol
irrigation rate is restored 1 s prior to the second application.
Biophysical tissue characteristics for the second application
account for the changes in thermal and electrical conductivity
resulting from the first application.
For B and C, we simulate a low-blood flow (0.1 m/s) for
atrium and ventricle, mimicking in the latter the less favorable
conditions for ablation and prone for complications, as those
that can be found in areas between papillary muscles and
cardiac wall.
RESULTS
A total of 432 RF ablation lesions are simulated by
applying the different predefined ablation parameters
(catheter tip design, CF, power, duration, saline
irrigation rate) and physiological scenarios (blood flow,
ablation site).
Safety of HPSD
The main findings are summarized in Figure 2 and
Supplementary Table 1. Five conclusions can be highlighted:
a. The safety margin of HPSD ablation is, in general, tight,
considering that several of the applications associate some
complications [342/432 (79%)]. This finding is more notable
in the atrium than in the ventricle [199/216 (92%) vs.
143/216 (66%)].
b. Limited electrode tip cooling, through saline flow and/or
blood flow, mostly leads to charring: at 17 ml/min, 94%
of applications with no-blood flow (45/48) lead to charring
in contrast with 15% with high-blood flow (7/48). Charring
largely appears at the very beginning of the application (<1 s).
Increasing the flushing rate avoids charring and allows to
continue the application, which is however often interrupted
shortly before the end because of the appearance of pop, as it
is the case in 67% of applications at 60 ml/min and no-blood
flow (32/48).
c. At low CF, all HPSD protocols exhibit low incidence of pop.
In the specific, pops occur in 31% of applications in the atrium
(17/54), and never (0/54) in the ventricle. Higher CF result safe
only in the ventricle, where 41% applications (66/162) are free
of pop for CF >5 g.
FIGURE 3 | Overall safety comparison of the two different catheter tip designs.
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d. Different catheter tip designs show varied behaviors
(Figure 3). Spherical tips appear relatively safe in both
chambers, while cylindrical tips only when used in the
ventricle. Nevertheless, cylindrical tips in the ventricle allow
the use of larger CF.
e. The complication distribution (charring vs. pop) is similar
for both catheters in the ventricle, whereas in the atrium the
spherical tip produces more charring and the cylindrical more
pops (Figure 3).
Efficacy of HPSD
In order to assess the efficacy of HPSD protocols, we considered
the safest setting emerged from the previous set. These are
identified from Figure 2 as the configurations that ensure a safe
termination for all protocols. These settings are represented by
CF 5 g, irrigation rate 60 ml/min, using a spherical tip in the
atrium and a cylindrical tip in the ventricle.
The analysis of the different HPSD protocols shows that as
power increases and duration diminishes, lesions tend to be
FIGURE 4 | Comparison between HPSD and standard ablation protocols in atrium (A) and ventricle (B). Radar charts show the percentage comparison against a
reference standard protocol (30 W/30 s in the atrium, 40 W/30 s in the ventricle). The associated tables present the absolute values. D, lesion depth; DW, Depth at
maximum width; V, volume; W, lesion width.
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narrower and shallower, resulting in a smaller volume (Figure 4).
High-power short-duration generates lesions that are always
more superficial than those obtained with standard protocols
but comparable in width. In the atrium HPSD lesions are
always smaller in volume than those obtained with standard
protocols, while in the ventricle HPSD lesions are smaller
when compared to the ones of the 40 W/30 s protocol, but
similar to the 30 W/30 s standard ones (with the exception
of the 90 W/4 s protocol whose lesions were consistently of
smaller volume).
FIGURE 5 | Lesion comparison between 90 W/4 s and standard protocols in the ventricle at different CF. The table collects the absolute values. (A) Comparison of 90
W/4 s vs. 30 W/30 s protocol at CF 5 and 20g; (B) comparison of 90 W/4 s vs. 40 W/30 s protocol at CF 5 and 20g.
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Additionally, we analyze the effect of increasing CF in the
ventricle for the 90 W/4 s protocol with a cylindrical catheter
which was the only HPSD setting that allowed safe applications
at higher CF. At CF 20 g, lesions become comparable to the
ones from standard 30 W/30 s protocols but remain markedly
smaller in volume than those from 40W/30 s protocols (Figure 5;
Supplementary Figure 1).
Repeated HPSD Applications
A second identical HPSD application on top of a first one is
simulated after a variable time interval. We consider a spherical
tip in the atrium and a cylindrical tip in the ventricle, CF 5 g, low-
blood flow and irrigation rate of 60 ml/min, in accordance with
the results of the first step. In general, all lesions increase in size
after a repeated application (Figure 6; Supplementary Table 2).
As the time interval between applications gets longer, lesion size
increase is reduced. Furthermore, as the interval decreases, the
risk of pop appearance is higher. For both cardiac chambers, the
80 W/6 s protocol shows the worst profile, requiring the longest
interval between both applications to avoid complications.
In the atrium, increase in width is more pronounced than
in depth, being more evident at 90 W/4 s. Only 70 W/8 s
applications with a 4-s interval reach a final lesion volume that
exceeds that of a lesion performed with a standard protocol
(Supplementary Figure 2).
In the ventricle, the lesion increases similarly in depth and
width. The best trade-off between safety and lesion increase is
reached with a 90 W/4 s protocol and 6-s interval (showing a
77% volume increase). The final lesion after a second application
is larger than the standard 30 W/30 s lesion for any HPSD
protocol, especially in terms of width, but generally of smaller
volume when compared to those obtained with 40 W/30 s
(Supplementary Figure 4).
DISCUSSION
This is the first study where an advanced virtual model is used to
systematically evaluate HPSD ablation in atrium and ventricle. In
addition, our innovative model provides a comprehensive insight
in the mechanisms of RF ablation, setting the basis for future
research in the field. The main advantage of a computer model
is that it enables a controlled introduction of a wide range of
parameters that influence lesion formation and produces direct
results. It circumvents the need for extensive statistical analysis
required by in-vivo and in-vitro experimentation where such
parameters are not always under control.
The major findings of the study are: 1. The safety margin of
HPSD is in general tight; 2. Catheter tip design and irrigation
rate are critical to ensure safe and efficient applications; 3. High-
power short-duration lesions are in general shallower and smaller
in volume compared to standard lesions; 4. A second HPSD
application after a suitable time lag increases lesion size.
Model Validation
Our model has been previously validated with standard in-vitro
ablation protocols of porcine tissue (11). For this setting, we
have shown that our lesions correlate well in depth but have a
tendency to slightly underestimate width. This is likely related
to an anisotropic electrical/thermal conduction in the tissue.
Nevertheless, since this anisotropic conduction has never been
evaluated neither in-vitro nor in-vivo, we had to use an isotropic
conduction for our model.
The study of Kotadia et al. (24) collects experimental data
on a variety of tissues, featuring several different protocols, both
standard and HPSD. Unfortunately, several details such as CF
and saline irrigation for the studies considered in their review
are incomplete. Moreover, as we observed in a previous study,
the interspecies variability in biophysical properties results in
non-negligible differences in the lesion size (25). Hence, a direct
validation of our HPSD result is not really feasible. Nevertheless,
we can observe (Table 2) an adequate correlation with depth and
a slight underestimation of width, for both HPSD and standard
protocols. Such consistency in width underestimation does not
hamper a fair comparison between our results for standard and
HPSD protocols.
Safety Margin of HPSD
The experience with standard RF protocols is wide and the
currently used have demonstrated to be mostly safe (2, 3).
High-power short-duration represents a new approach to RF
ablation aimed at reducing ablation time and overcoming
some limitations of standard protocols. In agreement with
the published data (9, 10), our results show that HPSD can
be effectively used, although its safety margin is narrow.
According to our study, the main determinants of complications
are the irrigation rate and the catheter tip design, the latter
mostly related to the chamber where RF is applied. To the
best of our knowledge, this is the first time that an association
between catheter tip shape, anatomical location of ablation
and safety is shown. These findings suggest that HPSD should
be clinically used with caution, additional technological safety
tools should be implemented in the catheters and generators,
and operators should use the technology strictly following
industry recommendations ensuring stable position and
adequate CF.
Influence of Catheter Tip Design
Catheter tip shape has a crucial impact on the safety profile of
HPSD. We observed that while a spherical catheter tip provides
the best trade-off between safety and efficacy in the atrium, the
opposite occurs in the ventricle.
A possible explanation can be found in the physics of
RF ablation. The power delivered to the tissue increases
proportionally to the percentage of the catheter tip that is in
contact with the endocardium (1), which is different for each
catheter according to the CF. At low CF, the entire base of
the cylindrical tip is in contact with the tissue, while only a
tiny portion of the spherical tip does so. Increasing the CF, the
tissue progressively deforms, and the contact surface increases
with the pressure. This increase is more pronounced for the
spherical tip. As a consequence, at low CF (<10 g) spherical tips
feature a smaller contact surface between tissue and electrode that
cylindrical tips, while as the CF increases (>10 g) this relationship
is reversed (Supplementary Figure 3). As a result, at low CF the
Frontiers in Medical Technology | www.frontiersin.org 8 November 2021 | Volume 3 | Article 747609
Petras et al. Virtual Characterization of HPSD Ablation
FIGURE 6 | Effect on lesion size from a second HPSD application on top of a first one as a function of the time interval between the two. Ablations are performed with
spherical tip in the atrium and cylindrical tip in the ventricle. The percentage increase in depth, width and volume is represented as bar charts for atrium (A) and
ventricle (B). Striped bars indicate a pop occurrence during the second application.
spherical tip delivers less power than the cylindrical one while
at high CF the opposite occurs. Heat dissipation in the thinner
atrial wall is lower (14), limiting the power that can be safely
delivered to this chamber. In this case, only the spherical tip at
low CF appears to remain within the safety margins. Contrarily,
the thicker ventricular wall allows higher power delivery, and the
cylindrical tip appears more effective and safer.
Although few studies have analyzed the role of
electrode tip shape on standard ablations, a similar
pattern was already observed with standard protocols in
previous in-vitro studies (12) comparing two commercially
available catheters, ThermoCool R© (Biosense Webster,
cylindrical design) and CoolPath R© (St Jude Medical,
spherical design).
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TABLE 2 | Comparison between HPSD and standard ablation protocols derived from several in-silico, ex-vivo, and in-vivo studies compiled by Kotadia et al. (24) against
the lesions simulated by our model in atrium and ventricle.
Protocol Energy Depth Width
(W/s) (J) (mm) (mm)
Kotadia et al. Virtual lesion Kotadia et al. Virtual lesion
Atrium Ventricle Atrium Ventricle
30 W/30 s 900 5.1–5.7 5.31 4.53 7.9–8.9 7.59 6.49
70 W/8 s 560 4.0–4.3 3.47 3.68 10.5–10.8 6.82 7.10
80 W/6 s 480 2.9–3.9 3.29 3.49 7.9–11.2 6.96 6.96
90 W/4 s 369 2.6–3.6 2.97 3.07 5.9–10.3 6.20 6.56
For that purpose, the power/s protocols are converted to total energy delivery. D, lesion depth; W, lesion width.
Catheter Tip Design and Effective Cooling
As previously demonstrated (26), the use of catheter cooling
systems allows larger power delivery preventing charring,
particularly in areas with poor blood flow. Based on our results,
a considerably high flushing rate (>30 ml/min) is necessary
to avoid charring, which can be a limitation for heart failure
patients. The spherical tip also led more frequently to charring,
especially in the atrium, possibly related to a larger surface of the
tip in contact with blood than with tissue.
Charringmostly appears in ourmodel at the interface between
the metallic tip and the rest of the catheter body. We replicate
a cooling system based on six distal coplanar pores, with saline
flowing out perpendicularly to the electrode surface. This is
probably not the most suitable configuration since the electrode-
body interface is not directly cooled down. This advocates for a
more efficient cooling system, which could be achieved by either
adding more pores distributed along the entire metallic tip, or by
forcing a directionality in the irrigation flow toward the upper
part of the electrode (6, 7).
HPSD Lesion Size and Shape
In the line of data reported in HPSD in-vitro experiments (6, 7,
24), HPSD lesions are wider than they are deep and, in general,
smaller in volume than those of standard protocols. This can be
expected since the total energy delivered by HPSD protocols is
lower than for the standard protocols (e.g., 360 J for a 90W/4 s vs.
900 J for a 30 W/30 s). However, the relationship between energy
delivery and lesion size is not the same for HPSD and standard
protocols. Increases in power, combined with shorter duration,
entail a decrease in depth accompanied by minor changes in
width. This can be explained by the distinctive biophysics of heat
transfer in HPSD protocols, since lesion generation is mainly
based on resistive heating, while conductive heating has only a
marginal role due to the short duration of the application (14).
This feature may prove advantageous in the atrium, allowing
to treat the arrhythmogenic substrate in its thin wall avoiding
complications in its vicinity. However, it may be insufficient
to reach deep targets as in the ventricle or for mitral annular
lines (27).
On the contrary, Leshem et al. (6) reported a better linear
continuity and transmurality with HPSD ablations than with
standard applications. However, this observation could be related
to other factors like catheter stability or constant CF during
application, more difficult to maintain during standard protocols
(6, 8).
HPSD Protocols Comparison
As power is increased and duration reduced shallower lesions are
generated with minimal change in width. In terms of safety, we
didn’t find any difference between HPSD protocols in the atrium.
In contrast, in the ventricle, the 90W/4 s protocol represented the
best power/duration balance to ensure safe lesions while the 80
W/6 s appeared to be the poorest. The 70 W/8 s protocol offered
a safe margin only at moderate CF.
Leshem (6) also identified the 90 W/4 s as the best
power/duration combination, allowing them to safely apply CF
as high as 40 g. Differently to our approach, these authors used
a highly sensitive and efficient temperature-controlled catheter
with rapid power downregulation at temperature >65◦C and a
cylindrical tip design with 64-pores, which can explain the wider
safety margin with respect to CF.
Effect of a Second Application
We observed a substantial increase in lesion size after
a second identical HPSD application, in opposition to
what is expected to occur with standard protocols (28).
According to thermodynamics, heat transfer within the
tissue continues until thermal equilibrium is reached. This
process is estimated to last 45–60 s which is close to the
end of application in standard protocols. The short duration
of HPSD protocols allows to exploit this thermal latency
period by rapidly adding a second application to increase the
lesion size.
We analyzed different intervals between applications. The
optimal interval was a trade-off between efficacy and safety: the
shorter the interval the larger the lesion size gain but, at the same
time, the higher the risk of pops.
Two additional findings should be highlighted. In the atrium,
the gain in lesion size was more evident in width than in
depth, which would potentially maximize the extension of atrial
lesions, while preserving neighboring structures. In the ventricle,
the second application achieved lesions comparable in size to
standard ones, notably reducing the ablation time.
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LIMITATIONS
Our advanced virtual model includes some variables which
influence the biophysics of RF ablation, making it comparable
to experimental models. The model assumes constancy of other
variables like catheter orientation, that cannot be fully controlled
in clinical practice and would probably change the characteristics
of the RF lesion. Due to a lack of data in this respect, we
are considering isotropic thermal and electrical conductivities,
which produce more spherically-shaped lesions. As the cardiac
tissue is not isotropic (fibers orientations, tissue composition),
this modeling choice is likely responsible for the lesion width
underestimation we observe with respect to some experimental
studies. In our opinion, although deserving further investigation,
these aspects don’t have a significant impact on the global results
of this study since they are common limitations for both standard
and HPSD protocols. The main objective of the study was to
explore the biophysical characteristics of HPSD in comparison
to standard RF protocols, therefore extrapolation to the clinical
setting should be made cautiously.
Our model assumes a power-controlled system, without
upper temperature limit. Adding a self-down-regulation of the
energy at a given tissue temperature would probably avoid
some complications observed in our simulations, but would
prevent a deeper understanding of the behavior of this type of
energy delivery.
The simulated applications were interrupted when blood or
tissue temperature reached complication thresholds. Our model
uses a simple six-pores irrigation system prone to charring
formation. The question lingers whether by using new catheters
with more effective irrigation system charring could have been
avoided and if so, whether pops would have occurred had the
applications continued. According to our simulations, enhanced
irrigation designs would have little impact on the risk of pop or
lesion size.
CONCLUSIONS
High-power short-duration ablation generates shallower and
smaller lesions than those of standard protocols. In the
atrium, these characteristics can be exploited to reach the
arrhythmogenic substrate preserving the neighboring structures.
In the ventricle, a second application can create lesions
comparable to the ones obtained with standard protocols in
shorter time. The safety margin of HPSD is narrow but seems to
be a valuable new clinical approach. For best outcomes, it should
be implemented cautiously and probably using ad-hoc designed
RF systems.
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